CYTOKINETICS INC — Director's Dealing 2021

Jul 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-07-19

Reporting Person: SMITH SANDFORD D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-07-19	Common Stock	M	5000	$10.68	Acquired	11459	Direct
2021-07-19	Common Stock	S	5000	$29.0	Disposed	6459	Direct
2021-07-19	Common Stock	M	1965	$10.68	Acquired	8424	Direct
2021-07-19	Common Stock	S	1965	$29.5	Disposed	6459	Direct
2021-07-19	Common Stock	M	5000	$10.68	Acquired	11459	Direct
2021-07-19	Common Stock	S	5000	$28.5	Disposed	6459	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-19	Non-Qualified Stock Option (right to buy)	$10.68	M	5000	Disposed	2029-05-15	Common Stock (5000)	Direct
2021-07-19	Non-Qualified Stock Option (right to buy)	$10.68	M	1965	Disposed	2029-05-15	Common Stock (1965)	Direct
2021-07-19	Non-Qualified Stock Option (right to buy)	$10.68	M	5000	Disposed	2029-05-15	Common Stock (5000)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 10, 2021.

F2: Amount includes 1,459 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.